Cognoa ASD Diagnosis Aid Validation Study

NACompletedINTERVENTIONAL
Enrollment

711

Participants

Timeline

Start Date

August 7, 2019

Primary Completion Date

June 5, 2020

Study Completion Date

August 31, 2020

Conditions
Autism Spectrum Disorder
Interventions
DIAGNOSTIC_TEST

Cognoa ASD diagnostic device

Cognoa device is intended to aid healthcare providers in diagnosing Autism Spectrum Disorder (ASD)

Trial Locations (16)

39465

MediSync Clinical Research Hattiesburg Clinic, Petal

45419

PriMed Clinical Research, Dayton

75024

Texas Child Neurology, Plano

78660

ARC Clinical Research Kelly Lane, Pflugerville

78726

ARC Clinical Research at Wilson Parke, Austin

78745

ARC Clinical Research William Cannon, Austin

85254

Melmed Center, Scottsdale

85258

The Nicholls Group, Scottsdale

90034

Private Practice, Los Angeles

92677

Orange County Child Neurology, Laguna Niguel

Pediatric Neurology of Orange County, Laguna Niguel

Private Practice, Laguna Niguel

94303

Private Practice, Palo Alto

98103

Private Practice, Seattle

98105

Seattle Children's Hospital, Seattle

98405

Multicare Health System - Mary Bridge Pediatrics, Tacoma

All Listed Sponsors
lead

Cognoa, Inc.

INDUSTRY

NCT04151290 - Cognoa ASD Diagnosis Aid Validation Study | Biotech Hunter | Biotech Hunter